NCT04905667View on ClinicalTrials.gov

Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ®

PHASE1CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

September 8, 2020

Study Completion Date

September 11, 2020

Conditions
Breast Cancer
Interventions
DRUG

GB221

6 mg/kg, single dose, intravenous infusion, 90-100 min

DRUG

Herceptin

6 mg/kg, single dose, intravenous infusion, 90-100 min

Trial Locations (1)

510799

The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou

Sponsors
All Listed Sponsors
lead

Genor Biopharma Co., Ltd.

INDUSTRY